Connect with us
Gage

Business News

Neimeth Pharmaceuticals records high Topline, as earnings stay downbeat

Neimeth International Pharmaceuticals Plc closed its books for the quarter with an impressive half-year financial scorecard, showing the highest revenue recorded in the corresponding period in the last six years.

Published

on

Neimeth Pharmaceuticals records high Topline, as earnings stay downbeat

Impressive Second Quarter Masks Poor Q1 Performance: Neimeth International Pharmaceuticals Plc closed its books for the quarter with an impressive half-year financial scorecard, showing the highest revenue recorded in the corresponding period in the last six years. The firm’s top-line grew by 11.25% to NGN976mn (vs. NGN877mn in H1:2018).

Both business segments — Pharmaceuticals and Animal Health — contributed immensely to the record-record performance. The pharmaceutical business grew by 10% to NGN958mn while the Animal Health business grew significantly by 129.98% to NGN18mn (vs. NGN8mn in H1:2018).

It is noteworthy that the second quarter accounted for 76.73% of total revenue
generated so far in the company’s financial year which ends in September. Hence, Year on
Year revenue growth pegged at 55.05%. The improved revenue performance in Q2:2018
came with a slight increase in trade receivables (+5.40%), at NGN622mn.

Although the firm appears to be recording growth in revenue, a significant proportion of it is held in receivables. Considering that this performance was an outlier in the history of first-halves, and going by past trends, we are projecting a moderate growth of 1.42% in revenue to NGN2.30bn for 2019FY.

Specta

Costs-to-Sales Rises above Trend: Cost to sales settled at 53.82%, higher than a six-year average of 50% in corresponding periods. All the elements of direct cost increased
during the period, with the most significant being the cost of raw materials consumed,
which grew by 48.92%.

Overall, the firm recorded a 31.39% growth in cost, from NGN400mn in H1:2018 to NGN525mn. Going by past trends, the firm records slightly higher cost to sales position in the second half of the year. Also, the industry-wide issue regarding the importation
of Active Pharmaceutical Ingredients (APIs) is expected to influence the upward movement
in cost. On a balance of factors, we have made a projection of 49.14% for cost-to-sales.

NEIMETH Narrowly Escapes a Loss Position: In H1:2019, the firm recorded significant
dip in earnings, which dropped by 81.57% to NGN5.44mn, from NGN29.54mn in H1:2018,
despite the cost savings on operating expenses. The woeful performance was a result of the contraction in gross profit by 5.61% and an increase in net exchange loss to NGN9.85mn, from NGN0.27mn in H1:2018. Therefore, the firm recorded a loss amounting of NGN139bn In Q1:2019, after four consecutive quarters of profits. The loss position was an aggregation of several shortcomings such as low demand, heightened cost-to-sales, increased distribution and marketing costs amongst others.

Deal book 300 x 250

Coronation ads

However, in the second quarter, the firm made a profit of NGN145mn which was sufficient enough to offset the loss made in the previous quarter, although inadequate to deliver growth in earnings. Following our projections in top-line and cost-to-sales, we have made a forecast of 10.30% for net margin, from an earnings level of NGN237mn in 2019FY.

Recommendation: We revised our 2019 expected EPS downwards to NGN0.12, on the back of lower earnings growth projections. However, we maintain our target P/E at 5.0x considering the low earnings reported during the period. Our target price has therefore been reviewed downwards from NGN1.00 to NGN0.62.


 

Contact Information
Brokerage and Retail Services
[email protected] (+234 905 569 0627)
[email protected] (+234 7080007861)
[email protected]
Investment Banking/Corporate Finance
[email protected] (+234 8060110856)
[email protected] (+234 808 536 5766)

Coronation ads

Stanbic IBTC
Click to comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Coronavirus

COVID-19: FG to disburse N10 billion for local vaccine production

The Minister of Health has disclosed that Nigeria is exploring options for the licensed production of COVID-19 vaccine.

Published

on

The Federal Government, through the Ministry of Finance, has announced the sum of N10billion for the production of vaccines in Nigeria, to fight the coronavirus.

This was disclosed by the Minister of Health, Dr Osagie Ehanire, at the daily Covid-19 briefing by the Presidential Task Force on Monday in Abuja.

  • “The Ministry of Finance has released N10billion to support domestic vaccine production. While we are working to develop our own vaccines, Nigeria is exploring options for licensed production, in collaboration with recognised institutions. We are also exploring the option of local production of the vaccines in the country.”

He also warned Nigerians to ignore news about vaccines being for sale in Nigeria, as the procedures to acquire vaccines have to pass through due process.

  • I advise all citizens to disregard these claims, as they are criminal. There are procedures for vaccine acquisition and use, which include appropriate regulations and certification by National Agency for Food and Drug and Administration and Control (NAFDAC).
  • “I advise against fake vaccines, as there is no one approved for use in the country. The National Primary Health Care Development Agency (NPHCDA) is the only authorised vaccine administrator in Nigeria.”

He also stated that as Nigeria is experiencing the second wave, the FG needs to change its response procedures through infection mitigations and vaccines.

  • “There is no doubting the fact that we are deeply into the second wave of the pandemic which requires that PTF and FMoH review our strategies to respond to the challenge. The Federal Ministry of Health has outlined three approaches to confront the pandemic – Infection mitigation, Therapeutics and Vaccines.”

What you should know 

  • Nairametrics reported in November 2020, that the Health Minister announced Nigeria’s plans to set up a vaccine production company in Nigeria to boost local COVID-19 vaccine production.

Specta
Continue Reading

Coronavirus

COVID-19 Update in Nigeria

On the 18th of January 2021, 1,617 new confirmed cases and 14 deaths were recorded in Nigeria

Published

on

The spread of novel Corona Virus Disease (COVID-19) in Nigeria continues to record significant increases as the latest statistics provided by the Nigeria Centre for Disease Control reveal Nigeria now has 112,004 confirmed cases.

On the 18th of January 2021, 1,617 new confirmed cases and 14 deaths were recorded in Nigeria.

To date, 112,004 cases have been confirmed, 89,939 cases have been discharged and 1,449 deaths have been recorded in 36 states and the Federal Capital Territory. A total of 1.17 million tests have been carried out as of January 17th, 2021 compared to 1.15 million tests a day earlier.

COVID-19 Case Updates- 18th January 2021,

  • Total Number of Cases – 112,004
  • Total Number Discharged – 89,939
  • Total Deaths – 1,449
  • Total Tests Carried out – 1,172,234

According to the NCDC, the 1,617 new cases were reported from 18 states- Lagos (776), Kaduna (147) Kwara (131), FCT (102), Plateau (78), Edo (59), Ogun (53), Osun (45), Rivers (37), Taraba (36), Nasarawa (34), Adamawa (33), Kano (26), Delta (20), Ebonyi (16), Bayelsa (11), Gombe(11) and Borno (2).

Meanwhile, the latest numbers bring Lagos state total confirmed cases to 41,400, followed by Abuja (14,700), Plateau (6,831), Kaduna (6,325),  Oyo (4,695), Rivers (4,429), Edo (3,320), Ogun (2,912), Kano (2,617), Delta (2,122), Ondo (2,070), Katsina (1,723), Kwara (1,697), Enugu (1,583), Gombe (1,500), Nasarawa (1,335), Ebonyi (1,275), Osun (1,260),  Abia (1,134), and Bauchi (1,107).

Specta

Borno State has recorded 867 cases, Imo (857), Sokoto (677), Akwa Ibom (667), Benue (657), Bayelsa (619), Adamawa (573), Niger (547), Anambra (515), Ekiti (473), Jigawa (425), Taraba (294), Kebbi (251), Yobe (211), Cross River (169),  Zamfara (162), while Kogi state has recorded 5 cases only.

READ ALSO: COVID-19: Western diplomats warn of disease explosion, poor handling by government

Lock Down and Curfew

In a move to combat the spread of the pandemic disease, President Muhammadu Buhari directed the cessation of all movements in Lagos and the FCT for an initial period of 14 days, which took effect from 11 pm on Monday, 30th March 2020.

The movement restriction, which was extended by another two weeks period, has been partially put on hold with some businesses commencing operations from May 4. On April 27th, 2020, Nigeria’s President, Muhammadu Buhari declared an overnight curfew from 8 pm to 6 am across the country, as part of new measures to contain the spread of the COVID-19. This comes along with the phased and gradual easing of lockdown measures in FCT, Lagos, and Ogun States, which took effect from Saturday, 2nd May 2020, at 9 am.

Coronation ads

On Monday, 29th June 2020 the federal government extended the second phase of the eased lockdown by 4 weeks and approved interstate movement outside curfew hours with effect from July 1, 2020. Also, on Monday 27th July 2020, the federal government extended the second phase of eased lockdown by an additional one week.

On Thursday, 6th August 2020 the federal government through the secretary to the Government of the Federation (SGF) and Chairman of the Presidential Task Force (PTF) on COVID-19 announced the extension of the second phase of eased lockdown by another four (4) weeks.

Governor Babajide Sanwo-Olu of Lagos State announced the closed down of the Eti-Osa Isolation Centre, with effect from Friday, 31st July 2020. He also mentioned that the Agidingbi Isolation Centre would also be closed and the patients relocated to a large capacity centre.

Due to the increased number of covid-19 cases in Nigeria, the Nigerian government ordered the reopening of Isolation and treatment centres in the country on Thursday, 10th December 2020.

Coronation ads

READ ALSO: Bill Gates says Trump’s WHO funding suspension is dangerous

Stanbic IBTC

 

Jaiz bank ads

 

 

Continue Reading

Around the World

US Capitol complex temporarily shut down

The US Capitol complex was shut down temporarily on Monday as a precautionary measure after a small fire broke out nearby.

Published

on

The US Capitol complex was shut down temporarily for about an hour on Monday as a precautionary measure after a small fire broke out nearby, highlighting the security concerns that are being raised days before the inauguration of President-elect Joe Biden.

The security concerns and the lockdown follows the January 6 attack on the US Capital by supporters of the outgoing US President, Donald Trump, after his encouragement and inciting comments, calling the Presidential election a fraud without any proof of evidence.

READ: President Trump says he won’t attend Joe Biden’s inauguration

Some of them even called for the death of the US Vice President, Mike Pence for presiding over the certification of Joe Biden’s November election victory.

While making the disclosure in a statement, the Capitol Police said that the lockdown has been lifted and the nearby fire contained.

Specta

The Acting Chief of the Capitol Police had said that the complex which comprises of the Capitol, its grounds and several buildings were shut down as a precautionary measure.

READ: US Supreme court dismisses Texas bid to overturn presidential election results

The US Secret Service in a tweet post on its official Twitter handle said, “Out of an abundance of caution the U.S. Capitol complex was temporarily shutdown. There is no threat to the public.’’

The city’s fire department in its tweet post said that firefighters put out a fire outside near the Capitol complex.

Coronation ads

The fire department said, “There were no injuries. This accounts for smoke that many have seen.”

READ: Huawei accuses the United States of hacking

What you should know

  • President-elect, Joe Biden is expected to be sworn in at the US Capitol on Wednesday amid an unprecedented cordon of security, with strict physical distancing measures in place due to threats of violent attacks in Washington and the rising cases of coronavirus infections.
  • Donald Trump, who is just fresh from a historic second impeachment from the congress had said he would not attend, although his deputy, Vice President Mike Pence, had given an indication that he would attend.

Continue Reading
Advertisement




Advertisement